This risk management expert has proof that officials knew the COVID jab was a bioweapon since 2005, and it was developed to remove 15% of the world's population, or about 700 million people, during the WHO's 'decade of vaccination.' Counting down, that target date is likely to be 2028.
https://articles.mercola.com/sites/articles/archive/2022/07/18/pfizer-covid-profits.aspx
How Pfizer Profited From the Pandemic
STORY AT-A-GLANCE
The COVID-19 pandemic has been a real boon to Pfizer. Not only has it doubled Pfizer’s annual revenue, it has also given the drugmaker unique weight in determining U.S. health policy — something that concerns even staunch vaccine-pushers like Dr. Paul Offit
Pfizer’s revenue in 2021 was $81.3 billion — approximately double that of 2020 — and the COVID shot accounted for $36.78 billion of that
Pfizer’s COVID jab dominates 70% of the U.S. and European markets, and Paxlovid, its COVID drug, has become a standard treatment choice in hospitals. This despite findings showing the shot doesn’t prevent infection or transmission, and that Paxlovid causes severe rebound and supercharges mutations
The U.S. had thrown away 82.2 million expired COVID jab doses as of mid-May 2022, yet the Biden administration ordered another 105 million doses at the end of June 2022 for a fall booster campaign that will cost taxpayers $3.2 billion
Pfizer’s contracts are almost exclusively slanted in Pfizer’s favor. They’re guaranteed payment while having no financial liability for injuries and deaths, and it appears this indemnification applies even if they were to be found guilty of fraud
____________________________________________________________________________________________
According to Kaiser Health News (KHN),1 the COVID-19 pandemic has been a real boon to Pfizer. Not only has it yielded “outsize benefits” in terms of profits, but it has also “given the drugmaker unusual weight in determining U.S. health policy.”
“Based on internal research, the company’s executives have frequently announced the next stage in the fight against the pandemic before government officials have had time to study the issue, annoying many experts in the medical field and leaving some patients unsure whom to trust,” KHN reporter Arthur Allen writes, adding:2
“When last year Bourla suggested that a booster shot would soon be needed, U.S. public health officials later followed, giving the impression that Pfizer was calling the tune.
Some public health experts and scientists worry these decisions were hasty, noting, for example, that although boosters with the mRNA shots produced by Moderna and Pfizer-BioNTech improve antibody protection initially, it generally doesn’t last.
Since January, Bourla has been saying that U.S. adults will probably all need annual booster shots, and senior FDA officials have indicated since April that they agree ... The company’s power worries some vaccinologists, who see its growing influence in a realm of medical decision-making traditionally led by independent experts ...
When President Biden in September 2021 offered boosters to Americans — not long after [Pfizer CEO Albert] Bourla had recommended them — Dr. Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia ... wondered, ‘Where’s the evidence you are at risk of serious disease when confronted with COVID if you are vaccinated and under 50?’
Policies on booster recommendations for different groups are complex and shifting, Offit said, but the CDC, rather than Bourla and Pfizer, should be making them. ‘We’re being pushed along,’ he said. ‘The pharmaceutical companies are acting like public health agencies.’”
The fact that a vaccine-pusher like Offit — infamous for claiming a baby can safely tolerate 10,000 vaccines at once3 — is questioning and pushing back against Pfizer’s influence over health policy reveals just how brazen, unethical and potentially dangerous that is.
Massive Profits Made From Useless Products
According to Allen, Pfizer’s revenue in 2021 was $81.3 billion4 — approximately double that of 2020 — and the COVID shot accounted for $36.78 billion5 of that. For comparison, Lipitor, Pfizer’s previous top selling statin, generates roughly $2 billion a year,6 while their strep vaccine, Prevnar 13 rakes in $6 billion a year.7
Its mRNA gene transfer injection against COVID now dominates 70% of the U.S. and European markets, and Paxlovid, Pfizer’s COVID drug, has become a standard treatment choice in hospitals. This, despite researchers finding Paxlovid (molnupiravir) causes severe rebound and supercharges mutations.
In a rational scenario, that finding would have put a stop to its use, but no. In an official health advisory8 to the public, issued May 24, 2022, the U.S. Centers for Disease Control and Prevention first warns that Paxlovid is associated with “recurrence of COVID-19 or ‘COVID-19 rebound,’” and then in the very next sentence stresses in bold print a narrative supporting its use and enriching Pfizer with instructions saying:
“Paxlovid continues to be recommended for early- stage treatment of mild to moderate COVID-19 among persons at high risk for progression to severe disease.”
Allen also notes that, during an investor call, a Pfizer official highlighted reports of Paxlovid’s failure, but spun it into “good news” for investors, as patients may require multiple courses!9 Obviously the objective has long ago shifted from helping humans to raping them for as much profit as possible.
Similarly, while Pfizer’s COVID jab clearly doesn’t prevent infection or spread, and Americans are rejecting the shots in growing numbers — 82.2 million doses had expired and were chucked in the trash as of mid-May 202210 — the U.S. government still went ahead and ordered another 105 million doses at the end of June 2022.
These are intended for a fall booster campaign, at a cost to taxpayers of $3.2 billion.11 The U.S. is actually paying about 50% more for each of these new jab boosters this time around — $30.47 per dose compared to $19.50 per dose paid for the first 100 million doses.
The U.S. government has also promised to purchase another 20 million courses of Paxlovid, at an eye-watering cost of $530 per five-day course. Basically, Pfizer is being financially rewarded for producing products that are useless at best and dangerous at worst, and we’re all paying for it. In case you’re curious, that is another $10.6 billion transferred from U.S. taxpayers to Pfizer.
Future Boosters Won’t Undergo Human Clinical Trials
After you likely thought it couldn’t ever get any worse, KHN also touches on, but doesn’t delve into, the fact that Pfizer suggested they skip human trials as they move forward with jabs that are reformulated for newer variants. If this strikes you as crazy, you’d be right. It’s sheer madness, but the U.S. Food and Drug Administration — a clearly captured agency — has already surreptitiously agreed to this egregious miscarriage of science.
How this wicked scheme, known as the “Future Framework,”12 was adopted by the FDA without formal vote is explained by Toby Rogers, Ph.D. — a political economist whose research focus is on regulatory capture and Big Pharma corruption13 — in the video above. He also explained it in a June 29, 2022, Substack article:14
“Yesterday [June 28], the FDA’s Vaccines and Related Biological Products Advisory Committee approved a bivalent COVID-19 shot with the Wuhan strain and the Omicron variant ... Wait, hold up, I thought the FDA was voting on the Future Framework yesterday?
The policy question was whether reformulated COVID-19 shots would be treated as new molecular entities (which they are) in which case they should be subject to formal review or whether reformulated shots would be treated as ‘biologically similar’ to existing Covid-19 shots and be allowed to skip clinical trials altogether.
Apparently the FDA did not have the votes to just pass this as a policy question. If you ask anyone whether reformulated mRNA represents a new molecular entity, well of course it is, so that would require formal regulatory review.
What the FDA did instead was to smuggle the policy question in disguised as a vote about reformulated ‘boosters’ for the fall.
In essence, the FDA just started doing the Future Framework (picking variants willy nilly, skipping clinical trials) and essentially dared the committee members to turn down a booster dose — knowing that all of the VRBPAC members are hand-picked because they’ve never met a vaccine they did not like.
So of course only two people on the committee had the courage to turn down a booster dose — even though it was based on this preposterous process (that was never formally adopted) where there was literally no data at all ... By stealth, the FDA replaced a system based on evidence with a system based entirely on belief.”
Countries Held to Ransom
In 2021, secret details of Pfizer’s contracts came to light, showing they are essentially holding countries hostage to nonnegotiable demands for payment in full AND freedom from liability.15
In late February 2021, The Bureau of Investigative Journalism reported16 that Pfizer was demanding countries put up sovereign assets as collateral for expected vaccine injury lawsuits resulting from its COVID-19 jab.
Several countries, including Brazil, Chile, Colombia, the Dominican Republic and Peru, agreed to this demand, putting up bank reserves, military bases and embassy buildings as collateral. In short, theses governments are guaranteeing Pfizer will be compensated for any expenses resulting from injury lawsuits against it, so the company won’t lose a dime if its COVID shot injures people.
Shockingly, these terms are binding even if those injuries are the result of negligent company practices, fraud or malice!
Government purchasers must acknowledge that the effectiveness and safety of the shots are completely unknown, all while indemnifying Pfizer against any and all financial liability.